{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T23:05:25Z","timestamp":1778108725814,"version":"3.51.4"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,3,18]],"date-time":"2015-03-18T00:00:00Z","timestamp":1426636800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurotox Res"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1007\/s12640-015-9526-z","type":"journal-article","created":{"date-parts":[[2015,3,17]],"date-time":"2015-03-17T10:03:59Z","timestamp":1426586639000},"page":"384-398","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Src Family Kinase Inhibitors Antagonize the Toxicity of Multiple Serotypes of Botulinum Neurotoxin in Human Embryonic Stem Cell-Derived Motor Neurons"],"prefix":"10.1007","volume":"27","author":[{"given":"Erkan","family":"Kiris","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James C.","family":"Burnett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan E.","family":"Nuss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura M.","family":"Wanner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian D.","family":"Peyser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao T.","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glenn Y.","family":"Gomba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krishna P.","family":"Kota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rekha G.","family":"Panchal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rick","family":"Gussio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher D.","family":"Kane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lino","family":"Tessarollo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sina","family":"Bavari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,3,18]]},"reference":[{"issue":"8","key":"9526_CR1","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1593\/neo.10328","volume":"12","author":"A Aleshin","year":"2010","unstructured":"Aleshin A, Finn RS (2010) SRC: a century of science brought to the clinic. Neoplasia 12(8):599\u2013607","journal-title":"Neoplasia"},{"issue":"Suppl 1","key":"9526_CR2","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1002\/(SICI)1099-1263(199912)19:1+<S23::AID-JAT609>3.0.CO;2-X","volume":"19","author":"JP Apland","year":"1999","unstructured":"Apland JP, Biser JA, Adler M, Ferrer-Montiel AV, Montal M, Canaves JM, Filbert MG (1999) Peptides that mimic the carboxy-terminal domain of SNAP-25 block acetylcholine release at an Aplysia synapse. J Appl Toxicol 19(Suppl 1):S23\u2013S26","journal-title":"J Appl Toxicol"},{"issue":"8","key":"9526_CR3","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/jama.285.8.1059","volume":"285","author":"SS Arnon","year":"2001","unstructured":"Arnon SS, Schechter R, Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Fine AD, Hauer J, Layton M, Lillibridge S, Osterholm MT, O\u2019Toole T, Parker G, Perl TM, Russell PK, Swerdlow DL, Tonat K (2001) Botulinum toxin as a biological weapon: medical and public health management. JAMA 285(8):1059\u20131070","journal-title":"JAMA"},{"issue":"11","key":"9526_CR4","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1038\/sj.embor.7400278","volume":"5","author":"M Bajohrs","year":"2004","unstructured":"Bajohrs M, Rickman C, Binz T, Davletov B (2004) A molecular basis underlying differences in the toxicity of botulinum serotypes A and E. EMBO Rep 5(11):1090\u20131095","journal-title":"EMBO Rep"},{"issue":"7","key":"9526_CR5","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1021\/bi001919y","volume":"40","author":"C Blanes-Mira","year":"2001","unstructured":"Blanes-Mira C, Ibanez C, Fernandez-Ballester G, Planells-Cases R, Perez-Paya E, Ferrer-Montiel A (2001) Thermal stabilization of the catalytic domain of botulinum neurotoxin E by phosphorylation of a single tyrosine residue. Biochemistry 40(7):2234\u20132242","journal-title":"Biochemistry"},{"issue":"18","key":"9526_CR6","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.2174\/1568026614666141022093857","volume":"14","author":"KM Bompiani","year":"2014","unstructured":"Bompiani KM, Dickerson TJ (2014) High-throughput screening technologies for botulinum neurotoxins. Curr Top Med Chem 14(18):2062\u20132080","journal-title":"Curr Top Med Chem"},{"issue":"7019","key":"9526_CR7","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/nature03123","volume":"432","author":"MA Breidenbach","year":"2004","unstructured":"Breidenbach MA, Brunger AT (2004) Substrate recognition strategy for botulinum neurotoxin serotype A. Nature 432(7019):925\u2013929. doi: 10.1038\/nature03123","journal-title":"Nature"},{"issue":"15","key":"9526_CR8","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1007\/s00018-008-8088-0","volume":"65","author":"AT Brunger","year":"2008","unstructured":"Brunger AT, Jin R, Breidenbach MA (2008) Highly specific interactions between botulinum neurotoxins and synaptic vesicle proteins. Cell Mol Life Sci 65(15):2296\u20132306. doi: 10.1007\/s00018-008-8088-0","journal-title":"Cell Mol Life Sci"},{"issue":"6","key":"9526_CR9","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1021\/cn200021q","volume":"2","author":"P Capek","year":"2011","unstructured":"Capek P, Zhang Y, Barlow DJ, Houseknecht KL, Smith GR, Dickerson TJ (2011) Enhancing the pharmacokinetic properties of botulinum neurotoxin serotype A protease inhibitors through rational design. ACS Chem Neurosci 2(6):288\u2013293","journal-title":"ACS Chem Neurosci"},{"issue":"11","key":"9526_CR10","doi-asserted-by":"crossref","first-page":"3066","DOI":"10.1158\/1535-7163.MCT-09-0151","volume":"8","author":"P Ceppi","year":"2009","unstructured":"Ceppi P, Papotti M, Monica V, Lo Iacono M, Saviozzi S, Pautasso M, Novello S, Mussino S, Bracco E, Volante M, Scagliotti GV (2009) Effects of Src kinase inhibition induced by dasatinib in non-small cell lung cancer cell lines treated with cisplatin. Mol Cancer Ther 8(11):3066\u20133074","journal-title":"Mol Cancer Ther"},{"issue":"10","key":"9526_CR11","doi-asserted-by":"crossref","first-page":"913","DOI":"10.3390\/toxins4100913","volume":"4","author":"S Chen","year":"2012","unstructured":"Chen S (2012) Clinical uses of botulinum neurotoxins: current indications, limitations and future developments. Toxins 4(10):913\u2013939","journal-title":"Toxins"},{"issue":"17","key":"9526_CR12","doi-asserted-by":"crossref","first-page":"15067","DOI":"10.1074\/jbc.M111.224493","volume":"286","author":"S Chen","year":"2011","unstructured":"Chen S, Barbieri JT (2011) Association of botulinum neurotoxin serotype A light chain with plasma membrane-bound SNAP-25. J Biol Chem 286(17):15067\u201315072","journal-title":"J Biol Chem"},{"issue":"2","key":"9526_CR13","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","volume":"70","author":"TC Chou","year":"2010","unstructured":"Chou TC (2010) Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Res 70(2):440\u2013446. doi: 10.1158\/0008-5472.CAN-09-1947","journal-title":"Cancer Res"},{"issue":"1","key":"9526_CR14","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1124\/jpet.108.147744","volume":"330","author":"JA Coffield","year":"2009","unstructured":"Coffield JA, Yan X (2009) Neuritogenic actions of botulinum neurotoxin A on cultured motor neurons. J Pharmacol Exp Ther 330(1):352\u2013358","journal-title":"J Pharmacol Exp Ther"},{"key":"9526_CR15","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/msb.2011.71","volume":"7","author":"M Cokol","year":"2011","unstructured":"Cokol M, Chua HN, Tasan M, Mutlu B, Weinstein ZB, Suzuki Y, Nergiz ME, Costanzo M, Baryshnikova A, Giaever G, Nislow C, Myers CL, Andrews BJ, Boone C, Roth FP (2011) Systematic exploration of synergistic drug pairs. Mol Syst Biol 7:544. doi: 10.1038\/msb.2011.71","journal-title":"Mol Syst Biol"},{"issue":"6","key":"9526_CR16","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1038\/leu.2011.390","volume":"26","author":"J Congleton","year":"2012","unstructured":"Congleton J, MacDonald R, Yen A (2012) Src inhibitors, PP2 and dasatinib, increase retinoic acid-induced association of Lyn and c-Raf (S259) and enhance MAPK-dependent differentiation of myeloid leukemia cells. Leukemia 26(6):1180\u20131188. doi: 10.1038\/leu.2011.390","journal-title":"Leukemia"},{"issue":"3","key":"9526_CR17","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0041-0101(96)00147-X","volume":"35","author":"SS Deshpande","year":"1997","unstructured":"Deshpande SS, Sheridan RE, Adler M (1997) Efficacy of certain quinolines as pharmacological antagonists in botulinum neurotoxin poisoning. Toxicon 35(3):433\u2013445","journal-title":"Toxicon"},{"issue":"3","key":"9526_CR18","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.coph.2009.03.004","volume":"9","author":"JO Dolly","year":"2009","unstructured":"Dolly JO, Lawrence GW, Meng J, Wang J, Ovsepian SV (2009) Neuro-exocytosis: botulinum toxins as inhibitory probes and versatile therapeutics. Curr Opin Pharmacol 9(3):326\u2013335","journal-title":"Curr Opin Pharmacol"},{"issue":"5773","key":"9526_CR19","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1126\/science.1123654","volume":"312","author":"M Dong","year":"2006","unstructured":"Dong M, Yeh F, Tepp WH, Dean C, Johnson EA, Janz R, Chapman ER (2006) SV2 is the protein receptor for botulinum neurotoxin A. Science 312(5773):592\u2013596. doi: 10.1126\/science.1123654","journal-title":"Science"},{"issue":"12","key":"9526_CR20","doi-asserted-by":"crossref","first-page":"5226","DOI":"10.1091\/mbc.E08-07-0765","volume":"19","author":"M Dong","year":"2008","unstructured":"Dong M, Liu H, Tepp WH, Johnson EA, Janz R, Chapman ER (2008) Glycosylated SV2A and SV2B mediate the entry of botulinum neurotoxin E into neurons. Mol Biol Cell 19(12):5226\u20135237. doi: 10.1091\/mbc.E08-07-0765","journal-title":"Mol Biol Cell"},{"issue":"1","key":"9526_CR21","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0014-5793(98)00571-7","volume":"429","author":"JA Encinar","year":"1998","unstructured":"Encinar JA, Fernandez A, Ferragut JA, Gonzalez-Ros JM, DasGupta BR, Montal M, Ferrer-Montiel A (1998) Structural stabilization of botulinum neurotoxins by tyrosine phosphorylation. FEBS Lett 429(1):78\u201382","journal-title":"FEBS Lett"},{"issue":"31","key":"9526_CR22","doi-asserted-by":"crossref","first-page":"18322","DOI":"10.1074\/jbc.271.31.18322","volume":"271","author":"AV Ferrer-Montiel","year":"1996","unstructured":"Ferrer-Montiel AV, Canaves JM, DasGupta BR, Wilson MC, Montal M (1996) Tyrosine phosphorylation modulates the activity of clostridial neurotoxins. J Biol Chem 271(31):18322\u201318325","journal-title":"J Biol Chem"},{"key":"9526_CR23","first-page":"115","volume":"364","author":"A Fischer","year":"2013","unstructured":"Fischer A (2013) Synchronized chaperone function of botulinum neurotoxin domains mediates light chain translocation into neurons. Curr Top Microbiol Immunol 364:115\u2013137. doi: 10.1007\/978-3-642-33570-9_6","journal-title":"Curr Top Microbiol Immunol"},{"issue":"5","key":"9526_CR24","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1073\/pnas.0812839106","volume":"106","author":"A Fischer","year":"2009","unstructured":"Fischer A, Nakai Y, Eubanks LM, Clancy CM, Tepp WH, Pellett S, Dickerson TJ, Johnson EA, Janda KD, Montal M (2009) Bimodal modulation of the botulinum neurotoxin protein-conducting channel. Proc Natl Acad Sci USA 106(5):1330\u20131335. doi: 10.1073\/pnas.0812839106","journal-title":"Proc Natl Acad Sci USA"},{"issue":"24","key":"9526_CR25","doi-asserted-by":"crossref","first-page":"5631","DOI":"10.1021\/bi9002138","volume":"48","author":"Z Fu","year":"2009","unstructured":"Fu Z, Chen C, Barbieri JT, Kim JJ, Baldwin MR (2009) Glycosylated SV2 and gangliosides as dual receptors for botulinum neurotoxin serotype F. Biochemistry 48(24):5631\u20135641. doi: 10.1021\/bi9002138","journal-title":"Biochemistry"},{"key":"9526_CR26","doi-asserted-by":"crossref","first-page":"e167","DOI":"10.1038\/cddis.2011.50","volume":"2","author":"CJ Garwood","year":"2011","unstructured":"Garwood CJ, Pooler AM, Atherton J, Hanger DP, Noble W (2011) Astrocytes are important mediators of Abeta-induced neurotoxicity and tau phosphorylation in primary culture. Cell Death Dis 2:e167. doi: 10.1038\/cddis.2011.50","journal-title":"Cell Death Dis"},{"issue":"4","key":"9526_CR27","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.tim.2010.02.001","volume":"18","author":"RM Hakami","year":"2010","unstructured":"Hakami RM, Ruthel G, Stahl AM, Bavari S (2010) Gaining ground: assays for therapeutics against botulinum neurotoxin. Trends Microbiol 18(4):164\u2013172","journal-title":"Trends Microbiol"},{"issue":"16","key":"9526_CR28","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1093\/hmg\/ddt192","volume":"22","author":"ML Hebron","year":"2013","unstructured":"Hebron ML, Lonskaya I, Moussa CE (2013) Nilotinib reverses loss of dopamine neurons and improves motor behavior via autophagic degradation of alpha-synuclein in Parkinson\u2019s disease models. Hum Mol Genet 22(16):3315\u20133328. doi: 10.1093\/hmg\/ddt192","journal-title":"Hum Mol Genet"},{"key":"9526_CR29","first-page":"123","volume":"636","author":"BY Hu","year":"2009","unstructured":"Hu BY, Zhang SC (2009) Directed differentiation of neural-stem cells and subtype-specific neurons from hESCs. Methods Mol Biol 636:123\u2013137","journal-title":"Methods Mol Biol"},{"issue":"4","key":"9526_CR30","doi-asserted-by":"crossref","first-page":"e19126","DOI":"10.1371\/journal.pone.0019126","volume":"6","author":"PP Huang","year":"2011","unstructured":"Huang PP, Khan I, Suhail MS, Malkmus S, Yaksh TL (2011) Spinal botulinum neurotoxin B: effects on afferent transmitter release and nociceptive processing. PLoS ONE 6(4):e19126","journal-title":"PLoS ONE"},{"issue":"1\u20132","key":"9526_CR31","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.febslet.2004.10.084","volume":"578","author":"C Ibanez","year":"2004","unstructured":"Ibanez C, Blanes-Mira C, Fernandez-Ballester G, Planells-Cases R, Ferrer-Montiel A (2004) Modulation of botulinum neurotoxin A catalytic domain stability by tyrosine phosphorylation. FEBS Lett 578(1\u20132):121\u2013127","journal-title":"FEBS Lett"},{"issue":"17","key":"9526_CR32","doi-asserted-by":"crossref","first-page":"5690","DOI":"10.1523\/JNEUROSCI.0265-09.2009","volume":"29","author":"TJ Kao","year":"2009","unstructured":"Kao TJ, Palmesino E, Kania A (2009) SRC family kinases are required for limb trajectory selection by spinal motor axons. J Neurosci 29(17):5690\u20135700","journal-title":"J Neurosci"},{"issue":"9","key":"9526_CR33","doi-asserted-by":"crossref","first-page":"e46185","DOI":"10.1371\/journal.pone.0046185","volume":"7","author":"R Katsumata","year":"2012","unstructured":"Katsumata R, Ishigaki S, Katsuno M, Kawai K, Sone J, Huang Z, Adachi H, Tanaka F, Urano F, Sobue G (2012) c-Abl inhibition delays motor neuron degeneration in the G93A mouse, an animal model of amyotrophic lateral sclerosis. PLoS One 7(9):e46185","journal-title":"PLoS One"},{"issue":"2","key":"9526_CR34","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1021\/bi0356698","volume":"43","author":"JE Keller","year":"2004","unstructured":"Keller JE, Cai F, Neale EA (2004) Uptake of botulinum neurotoxin into cultured neurons. Biochemistry 43(2):526\u2013532","journal-title":"Biochemistry"},{"issue":"3","key":"9526_CR35","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.scr.2011.01.002","volume":"6","author":"E Kiris","year":"2011","unstructured":"Kiris E, Nuss JE, Burnett JC, Kota KP, Koh DC, Wanner LM, Torres-Melendez E, Gussio R, Tessarollo L, Bavari S (2011) Embryonic stem cell-derived motoneurons provide a highly sensitive cell culture model for botulinum neurotoxin studies, with implications for high-throughput drug discovery. Stem Cell Res 6(3):195\u2013205. doi: 10.1016\/j.scr.2011.01.002","journal-title":"Stem Cell Res"},{"issue":"18","key":"9526_CR36","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.2174\/1568026614666141022093350","volume":"14","author":"E Kiris","year":"2014","unstructured":"Kiris E, Burnett JC, Kane CD, Bavari S (2014a) Recent advances in botulinum neurotoxin inhibitor development. Curr Top Med Chem 14(18):2044\u20132061. doi: 10.2174\/1568026614666141022093350","journal-title":"Curr Top Med Chem"},{"issue":"2","key":"9526_CR37","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1586\/14737159.2014.867808","volume":"14","author":"E Kiris","year":"2014","unstructured":"Kiris E, Kota KP, Burnett JC, Soloveva V, Kane CD, Bavari S (2014b) Recent developments in cell-based assays and stem cell technologies for botulinum neurotoxin research and drug discovery. Expert Rev Mol Diagn 14(2):153\u2013168. doi: 10.1586\/14737159.2014.867808","journal-title":"Expert Rev Mol Diagn"},{"issue":"4","key":"9526_CR38","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/BF03033911","volume":"12","author":"RM Kostrzewa","year":"2007","unstructured":"Kostrzewa RM, Segura-Aguilar J (2007) Botulinum neurotoxin: evolution from poison, to research tool\u2013onto medicinal therapeutic and future pharmaceutical panacea. Neurotox Res 12(4):275\u2013290","journal-title":"Neurotox Res"},{"key":"9526_CR39","first-page":"e51915","volume":"93","author":"KP Kota","year":"2014","unstructured":"Kota KP, Soloveva V, Wanner LM, Gomba G, Kiris E, Panchal RG, Kane CD, Bavari S (2014) A high content imaging assay for identification of botulinum neurotoxin inhibitors. J Vis Exp 93:e51915. doi: 10.3791\/51915","journal-title":"J Vis Exp"},{"key":"9526_CR40","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/ddr.20304","volume":"70","author":"JC Larsen","year":"2009","unstructured":"Larsen JC (2009) US army botulinum neurotoxin (BoNT) medical therapeutics research program: past accomplishments and future directions. Drug Dev Res 70:266\u2013278","journal-title":"Drug Dev Res"},{"issue":"1","key":"9526_CR41","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1523\/JNEUROSCI.4933-08.2010","volume":"30","author":"CG Lau","year":"2010","unstructured":"Lau CG, Takayasu Y, Rodenas-Ruano A, Paternain AV, Lerma J, Bennett MV, Zukin RS (2010) SNAP-25 is a target of protein kinase C phosphorylation critical to NMDA receptor trafficking. J Neurosci 30(1):242\u2013254. doi: 10.1523\/JNEUROSCI.4933-08.2010","journal-title":"J Neurosci"},{"issue":"5","key":"9526_CR42","doi-asserted-by":"crossref","first-page":"978","DOI":"10.3390\/toxins2050978","volume":"2","author":"FJ Lebeda","year":"2010","unstructured":"Lebeda FJ, Cer RZ, Mudunuri U, Stephens R, Singh BR, Adler M (2010) The zinc-dependent protease activity of the botulinum neurotoxins. Toxins 2(5):978\u2013997. doi: 10.3390\/toxins2050978","journal-title":"Toxins"},{"issue":"8","key":"9526_CR43","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1634\/stemcells.2007-0097","volume":"25","author":"H Lee","year":"2007","unstructured":"Lee H, Shamy GA, Elkabetz Y, Schofield CM, Harrsion NL, Panagiotakos G, Socci ND, Tabar V, Studer L (2007) Directed differentiation and transplantation of human embryonic stem cell-derived motoneurons. Stem Cells 25(8):1931\u20131939","journal-title":"Stem Cells"},{"issue":"7","key":"9526_CR44","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/nbt.1549","volume":"27","author":"J Lehar","year":"2009","unstructured":"Lehar J, Krueger AS, Avery W, Heilbut AM, Johansen LM, Price ER, Rickles RJ, Short GF 3rd, Staunton JE, Jin X, Lee MS, Zimmermann GR, Borisy AA (2009) Synergistic drug combinations tend to improve therapeutically relevant selectivity. Nat Biotechnol 27(7):659\u2013666. doi: 10.1038\/nbt.1549","journal-title":"Nat Biotechnol"},{"issue":"4","key":"9526_CR45","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1634\/stemcells.2007-0620","volume":"26","author":"XJ Li","year":"2008","unstructured":"Li XJ, Hu BY, Jones SA, Zhang YS, Lavaute T, Du ZW, Zhang SC (2008) Directed differentiation of ventral spinal progenitors and motor neurons from human embryonic stem cells by small molecules. Stem Cells 26(4):886\u2013893","journal-title":"Stem Cells"},{"issue":"24","key":"9526_CR46","doi-asserted-by":"crossref","first-page":"7338","DOI":"10.1016\/j.bmc.2011.10.062","volume":"19","author":"B Li","year":"2011","unstructured":"Li B, Cardinale SC, Butler MM, Pai R, Nuss JE, Peet NP, Bavari S, Bowlin TL (2011a) Time-dependent botulinum neurotoxin serotype A metalloprotease inhibitors. Bioorg Med Chem 19(24):7338\u20137348. doi: 10.1016\/j.bmc.2011.10.062","journal-title":"Bioorg Med Chem"},{"issue":"1","key":"9526_CR47","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3390\/molecules16010202","volume":"16","author":"B Li","year":"2011","unstructured":"Li B, Peet NP, Butler MM, Burnett JC, Moir DT, Bowlin TL (2011b) Small molecule inhibitors as countermeasures for botulinum neurotoxin intoxication. Molecules 16(1):202\u2013220. doi: 10.3390\/molecules16010202","journal-title":"Molecules"},{"issue":"2","key":"9526_CR48","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.nbd.2008.01.006","volume":"30","author":"DZ Liu","year":"2008","unstructured":"Liu DZ, Cheng XY, Ander BP, Xu H, Davis RR, Gregg JP, Sharp FR (2008) Src kinase inhibition decreases thrombin-induced injury and cell cycle re-entry in striatal neurons. Neurobiol Dis 30(2):201\u2013211","journal-title":"Neurobiol Dis"},{"issue":"4","key":"9526_CR49","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/7243","volume":"2","author":"WY Lu","year":"1999","unstructured":"Lu WY, Xiong ZG, Lei S, Orser BA, Dudek E, Browning MD, MacDonald JF (1999) G-protein-coupled receptors act via protein kinase C and Src to regulate NMDA receptors. Nat Neurosci 2(4):331\u2013338. doi: 10.1038\/7243","journal-title":"Nat Neurosci"},{"issue":"8","key":"9526_CR50","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1016\/j.febslet.2006.02.074","volume":"580","author":"S Mahrhold","year":"2006","unstructured":"Mahrhold S, Rummel A, Bigalke H, Davletov B, Binz T (2006) The synaptic vesicle protein 2C mediates the uptake of botulinum neurotoxin A into phrenic nerves. FEBS Lett 580(8):2011\u20132014","journal-title":"FEBS Lett"},{"issue":"22","key":"9526_CR51","doi-asserted-by":"crossref","first-page":"17209","DOI":"10.1074\/jbc.M109.098814","volume":"285","author":"J McNeish","year":"2010","unstructured":"McNeish J, Roach M, Hambor J, Mather RJ, Weibley L, Lazzaro J, Gazard J, Schwarz J, Volkmann R, Machacek D, Stice S, Zawadzke L, O\u2019Donnell C, Hurst R (2010) High-throughput screening in embryonic stem cell-derived neurons identifies potentiators of alpha-amino-3-hydroxyl-5-methyl-4-isoxazolepropionate-type glutamate receptors. J Biol Chem 285(22):17209\u201317217","journal-title":"J Biol Chem"},{"issue":"1","key":"9526_CR52","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.bbrc.2010.12.132","volume":"405","author":"P McNutt","year":"2011","unstructured":"McNutt P, Celver J, Hamilton T, Mesngon M (2011) Embryonic stem cell-derived neurons are a novel, highly sensitive tissue culture platform for botulinum research. Biochem Biophys Res Commun 405(1):85\u201390. doi: 10.1016\/j.bbrc.2010.12.132","journal-title":"Biochem Biophys Res Commun"},{"issue":"Pt 13","key":"9526_CR53","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1242\/jcs.068445","volume":"123","author":"M Messa","year":"2010","unstructured":"Messa M, Congia S, Defranchi E, Valtorta F, Fassio A, Onofri F, Benfenati F (2010) Tyrosine phosphorylation of synapsin I by Src regulates synaptic-vesicle trafficking. J Cell Sci 123(Pt 13):2256\u20132265","journal-title":"J Cell Sci"},{"issue":"3","key":"9526_CR54","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.coph.2004.12.006","volume":"5","author":"C Montecucco","year":"2005","unstructured":"Montecucco C, Molgo J (2005) Botulinal neurotoxins: revival of an old killer. Curr Opin Pharmacol 5(3):274\u2013279","journal-title":"Curr Opin Pharmacol"},{"issue":"8","key":"9526_CR55","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1177\/1087057110374996","volume":"15","author":"JE Nuss","year":"2010","unstructured":"Nuss JE, Wanner LM, Tressler LE, Bavari S (2010) The osmolyte trimethylamine N-oxide (TMAO) increases the proteolytic activity of botulinum neurotoxin light chains A, B, and E: implications for enhancing analytical assay sensitivity. J Biomol Screen 15(8):928\u2013936. doi: 10.1177\/1087057110374996","journal-title":"J Biomol Screen"},{"issue":"12","key":"9526_CR56","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.tins.2011.09.005","volume":"34","author":"H Ohnishi","year":"2011","unstructured":"Ohnishi H, Murata Y, Okazawa H, Matozaki T (2011) Src family kinases: modulators of neurotransmitter receptor function and behavior. Trends Neurosci 34(12):629\u2013637. doi: 10.1016\/j.tins.2011.09.005","journal-title":"Trends Neurosci"},{"issue":"14","key":"9526_CR57","doi-asserted-by":"crossref","first-page":"5860","DOI":"10.1021\/jm4006077","volume":"56","author":"IM Opsenica","year":"2013","unstructured":"Opsenica IM, Tot M, Gomba L, Nuss JE, Sciotti RJ, Bavari S, Burnett JC, Solaja BA (2013) 4-Amino-7-chloroquinolines: probing ligand efficiency provides botulinum neurotoxin serotype A light chain inhibitors with significant antiprotozoal activity. J Med Chem 56(14):5860\u20135871. doi: 10.1021\/jm4006077","journal-title":"J Med Chem"},{"issue":"3","key":"9526_CR58","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1517\/17460441.2014.884066","volume":"9","author":"K Patel","year":"2014","unstructured":"Patel K, Cai S, Singh BR (2014) Current strategies for designing antidotes against botulinum neurotoxins. Expert Opin Drug Discov 9(3):319\u2013333. doi: 10.1517\/17460441.2014.884066","journal-title":"Expert Opin Drug Discov"},{"key":"9526_CR59","first-page":"257","volume":"364","author":"S Pellett","year":"2013","unstructured":"Pellett S (2013) Progress in cell based assays for botulinum neurotoxin detection. Curr Top Microbiol Immunol 364:257\u2013285. doi: 10.1007\/978-3-642-33570-9_12","journal-title":"Curr Top Microbiol Immunol"},{"issue":"25","key":"9526_CR60","doi-asserted-by":"crossref","first-page":"4803","DOI":"10.1016\/j.febslet.2007.08.078","volume":"581","author":"S Pellett","year":"2007","unstructured":"Pellett S, Tepp WH, Clancy CM, Borodic GE, Johnson EA (2007) A neuronal cell-based botulinum neurotoxin assay for highly sensitive and specific detection of neutralizing serum antibodies. FEBS Lett 581(25):4803\u20134808","journal-title":"FEBS Lett"},{"issue":"3","key":"9526_CR61","doi-asserted-by":"crossref","first-page":"e1002008","DOI":"10.1371\/journal.ppat.1002008","volume":"7","author":"L Peng","year":"2011","unstructured":"Peng L, Tepp WH, Johnson EA, Dong M (2011) Botulinum neurotoxin D uses synaptic vesicle protein SV2 and gangliosides as receptors. PLoS Pathog 7(3):e1002008. doi: 10.1371\/journal.ppat.1002008","journal-title":"PLoS Pathog"},{"issue":"1","key":"9526_CR62","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1128\/IAI.69.1.570-574.2001","volume":"69","author":"DD Pless","year":"2001","unstructured":"Pless DD, Torres ER, Reinke EK, Bavari S (2001) High-affinity, protective antibodies to the binding domain of botulinum neurotoxin type A. Infect Immun 69(1):570\u2013574","journal-title":"Infect Immun"},{"issue":"8","key":"9526_CR63","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nrmicro3295","volume":"12","author":"O Rossetto","year":"2014","unstructured":"Rossetto O, Pirazzini M, Montecucco C (2014) Botulinum neurotoxins: genetic, structural and mechanistic insights. Nat Rev Microbiol 12(8):535\u2013549. doi: 10.1038\/nrmicro3295","journal-title":"Nat Rev Microbiol"},{"issue":"4","key":"9526_CR64","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nrn1368","volume":"5","author":"MW Salter","year":"2004","unstructured":"Salter MW, Kalia LV (2004) Src kinases: a hub for NMDA receptor regulation. Nat Rev Neurosci 5(4):317\u2013328","journal-title":"Nat Rev Neurosci"},{"issue":"19","key":"9526_CR65","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.2174\/092986711796150531","volume":"18","author":"S Schenone","year":"2011","unstructured":"Schenone S, Brullo C, Musumeci F, Biava M, Falchi F, Botta M (2011) Fyn kinase in brain diseases and cancer: the search for inhibitors. Curr Med Chem 18(19):2921\u20132942","journal-title":"Curr Med Chem"},{"key":"9526_CR66","first-page":"865819","volume":"2011","author":"B Sen","year":"2011","unstructured":"Sen B, Johnson FM (2011) Regulation of SRC family kinases in human cancers. J Signal Transduct 2011:865819","journal-title":"J Signal Transduct"},{"issue":"1","key":"9526_CR67","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1523\/JNEUROSCI.2352-07.2008","volume":"28","author":"Y Shu","year":"2008","unstructured":"Shu Y, Liu X, Yang Y, Takahashi M, Gillis KD (2008) Phosphorylation of SNAP-25 at Ser187 mediates enhancement of exocytosis by a phorbol ester in INS-1 cells. J Neurosci 28(1):21\u201330","journal-title":"J Neurosci"},{"issue":"30","key":"9526_CR68","doi-asserted-by":"crossref","first-page":"21145","DOI":"10.1074\/jbc.M800610200","volume":"283","author":"S Sikorra","year":"2008","unstructured":"Sikorra S, Henke T, Galli T, Binz T (2008) Substrate recognition mechanism of VAMP\/synaptobrevin-cleaving clostridial neurotoxins. J Biol Chem 283(30):21145\u201321152. doi: 10.1074\/jbc.M800610200","journal-title":"J Biol Chem"},{"issue":"9","key":"9526_CR69","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1021\/ja910761y","volume":"132","author":"P Silhar","year":"2010","unstructured":"Silhar P, Capkova K, Salzameda NT, Barbieri JT, Hixon MS, Janda KD (2010) Botulinum neurotoxin A protease: discovery of natural product exosite inhibitors. J Am Chem Soc 132(9):2868\u20132869. doi: 10.1021\/ja910761y","journal-title":"J Am Chem Soc"},{"issue":"1","key":"9526_CR70","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1385\/CBB:45:1:111","volume":"45","author":"DA Snyder","year":"2006","unstructured":"Snyder DA, Kelly ML, Woodbury DJ (2006) SNARE complex regulation by phosphorylation. Cell Biochem Biophys 45(1):111\u2013123. doi: 10.1385\/CBB:45:1:111","journal-title":"Cell Biochem Biophys"},{"issue":"9","key":"9526_CR71","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.3201\/eid1009.030745","volume":"10","author":"J Sobel","year":"2004","unstructured":"Sobel J, Tucker N, Sulka A, McLaughlin J, Maslanka S (2004) Foodborne botulism in the United States, 1990-2000. Emerg Infect Dis 10(9):1606\u20131611. doi: 10.3201\/eid1009.030745","journal-title":"Emerg Infect Dis"},{"issue":"7","key":"9526_CR72","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.febslet.2014.02.034","volume":"588","author":"J Strotmeier","year":"2014","unstructured":"Strotmeier J, Mahrhold S, Krez N, Janzen C, Lou J, Marks JD, Binz T, Rummel A (2014) Identification of the synaptic vesicle glycoprotein 2 receptor binding site in botulinum neurotoxin A. FEBS Lett 588(7):1087\u20131093. doi: 10.1016\/j.febslet.2014.02.034","journal-title":"FEBS Lett"},{"issue":"3","key":"9526_CR73","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.neuron.2013.10.022","volume":"80","author":"TC Sudhof","year":"2013","unstructured":"Sudhof TC (2013) Neurotransmitter release: the last millisecond in the life of a synaptic vesicle. Neuron 80(3):675\u2013690. doi: 10.1016\/j.neuron.2013.10.022","journal-title":"Neuron"},{"issue":"28","key":"9526_CR74","doi-asserted-by":"crossref","first-page":"5655","DOI":"10.1021\/bi3004928","volume":"51","author":"S Sun","year":"2012","unstructured":"Sun S, Tepp WH, Johnson EA, Chapman ER (2012) Botulinum neurotoxins B and E translocate at different rates and exhibit divergent responses to GT1b and low pH. Biochemistry 51(28):5655\u20135662. doi: 10.1021\/bi3004928","journal-title":"Biochemistry"},{"key":"9526_CR75","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3389\/fphar.2012.00102","volume":"3","author":"S Toth","year":"2012","unstructured":"Toth S, Brueggmann EE, Oyler GA, Smith LA, Hines HB, Ahmed SA (2012) Tyrosine phosphorylation of botulinum neurotoxin protease domains. Front Pharmacol 3:102","journal-title":"Front Pharmacol"},{"issue":"10","key":"9526_CR76","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.1021\/jm500033r","volume":"57","author":"M Videnovic","year":"2014","unstructured":"Videnovic M, Opsenica DM, Burnett JC, Gomba L, Nuss JE, Selakovic Z, Konstantinovic J, Krstic M, Segan S, Zlatovic M, Sciotti RJ, Bavari S, Solaja BA (2014) Second generation steroidal 4-aminoquinolines are potent, dual-target inhibitors of the botulinum neurotoxin serotype A metalloprotease and P. falciparum malaria. J Med Chem 57(10):4134\u20134153. doi: 10.1021\/jm500033r","journal-title":"J Med Chem"},{"issue":"28","key":"9526_CR77","doi-asserted-by":"crossref","first-page":"9984","DOI":"10.1073\/pnas.0408526102","volume":"102","author":"LM Wein","year":"2005","unstructured":"Wein LM, Liu Y (2005) Analyzing a bioterror attack on the food supply: the case of botulinum toxin in milk. Proc Natl Acad Sci USA 102(28):9984\u20139989","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"9526_CR78","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/toxsci\/kfr354","volume":"126","author":"RC Whitemarsh","year":"2012","unstructured":"Whitemarsh RC, Strathman MJ, Chase LG, Stankewicz C, Tepp WH, Johnson EA, Pellett S (2012) Novel application of human neurons derived from induced pluripotent stem cells for highly sensitive botulinum neurotoxin detection. Toxicol Sci 126(2):426\u2013435. doi: 10.1093\/toxsci\/kfr354","journal-title":"Toxicol Sci"},{"issue":"23","key":"9526_CR79","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1007\/s00018-006-6081-z","volume":"63","author":"A Wiesner","year":"2006","unstructured":"Wiesner A, Fuhrer C (2006) Regulation of nicotinic acetylcholine receptors by tyrosine kinases in the peripheral and central nervous system: same players, different roles. Cell Mol Life Sci 63(23):2818\u20132828. doi: 10.1007\/s00018-006-6081-z","journal-title":"Cell Mol Life Sci"},{"issue":"3","key":"9526_CR80","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1085\/jgp.200609685","volume":"129","author":"Y Yang","year":"2007","unstructured":"Yang Y, Craig TJ, Chen X, Ciufo LF, Takahashi M, Morgan A, Gillis KD (2007) Phosphomimetic mutation of Ser-187 of SNAP-25 increases both syntaxin binding and highly Ca2+-sensitive exocytosis. J Gen Physiol 129(3):233\u2013244. doi: 10.1085\/jgp.200609685","journal-title":"J Gen Physiol"},{"issue":"3","key":"9526_CR81","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.tips.2011.11.002","volume":"33","author":"S Zhang","year":"2012","unstructured":"Zhang S, Yu D (2012) Targeting Src family kinases in anti-cancer therapies: turning promise into triumph. Trends Pharmacol Sci 33(3):122\u2013128","journal-title":"Trends Pharmacol Sci"}],"container-title":["Neurotoxicity Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-015-9526-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12640-015-9526-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-015-9526-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T09:31:29Z","timestamp":1559467889000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12640-015-9526-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,18]]},"references-count":81,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["9526"],"URL":"https:\/\/doi.org\/10.1007\/s12640-015-9526-z","relation":{},"ISSN":["1029-8428","1476-3524"],"issn-type":[{"value":"1029-8428","type":"print"},{"value":"1476-3524","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,18]]}}}